Literature DB >> 2692127

Immunological and bacteriological aspects of reactive arthritis.

A Toivanen1, K Granfors, R Lahesmaa-Rantala, P Toivanen.   

Abstract

It is apparent that in the development of reactive arthritis the patient fails in his first line of defence against the invading microorganism. This results in persistence of the microorganism probably in or close to the intestinal epithelium. Microbial antigens may appear also in the circulation, perhaps as part of the immune complexes, or within cellular elements. Through these transportation mechanisms they enter the synovium, triggering an inflammatory process that leads to reactive arthritis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2692127     DOI: 10.1007/bf00271881

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  16 in total

1.  Immunoblot analysis of human IgM, IgG and IgA responses to plasmid-encoded antigens of Yersinia enterocolitica serovar O3.

Authors:  T H Ståhlberg; K Granfors; A Toivanen
Journal:  J Med Microbiol       Date:  1987-09       Impact factor: 2.472

2.  HL-A antigen 27 and reactive arthritis.

Authors:  K Aho; P Ahvonen; A Lassus; K Sievers; A Tilikainen
Journal:  Lancet       Date:  1973-07-21       Impact factor: 79.321

3.  Expression of the temperature-inducible outer membrane proteins of yersiniae.

Authors:  I Bölin; D A Portnoy; H Wolf-Watz
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

4.  IgA-anti-yersinia antibodies in yersinia triggered reactive arthritis.

Authors:  K Granfors; A Toivanen
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

5.  Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis.

Authors:  K Granfors; M Viljanen; A Tiilikainen; A Toivanen
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

6.  An outbreak of Yersinia pseudotuberculosis infection.

Authors:  R Tertti; K Granfors; O P Lehtonen; J Mertsola; A L Mäkelä; I Välimäki; P Hänninen; A Toivanen
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

7.  Association of persisting IgA response with yersinia triggered reactive arthritis: a study on 104 patients.

Authors:  A Toivanen; R Lahesmaa-Rantala; R Vuento; K Granfors
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

8.  Circulating yersinia specific immune complexes after acute yersiniosis: a follow up study of patients with and without reactive arthritis.

Authors:  R Lahesmaa-Rantala; K Granfors; R Kekomäki; A Toivanen
Journal:  Ann Rheum Dis       Date:  1987-02       Impact factor: 19.103

9.  Depressed lymphocyte transformation by yersinia and Escherichia coli in yersinia arthritis.

Authors:  R Leino; R Vuento; S Koskimies; M Viander; A Toivanen
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

10.  Chlamydia trachomatis and reactive arthritis: the missing link.

Authors:  A Keat; B Thomas; J Dixey; M Osborn; C Sonnex; D Taylor-Robinson
Journal:  Lancet       Date:  1987-01-10       Impact factor: 79.321

View more
  1 in total

1.  Long term follow up of SHR rats with experimental yersinia associated arthritis.

Authors:  R Merilahti-Palo; C Gripenberg-Lerche; K O Söderström; P Toivanen
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.